Located at the Centre for Process Innovation (CPI), Teesside, Calysta will develop the production process for FeedKind™ protein, a new fish feed ingredient to reduce the aquaculture industry’s use of fishmeal. FeedKind™ protein – a natural, safe, non-GMO sustainable fish feed ingredient is approved for sale in the European Union.
Calysta (UK) Ltd has received a conditional award of up to £2.8 million Exceptional Regional Growth Fund (eRGF) grant subject to due diligence from the UK Government. This will contribute to a £30 million first phase investment over ten years by Calysta to develop a Market Introduction Facility to undertake R&D.
The project is expected to both safeguard and create up to 39 positions in science, engineering and operations, along with indirect jobs benefits in construction and the supply chain.
Calysta plan to locate a novel loop reactor adjacent to CPI’s existing National Industrial Biotechnology Facility. This loop reactor will incorporate Calysta’s proprietary, best-in-class gas fermentation technology. CPI staff will then gain experience in operating the facility under Calysta’s supervision.
Alan Shaw, Ph.D., Calysta president and CEO said: “The eRGF grant is a major vote of confidence for us from the UK Government. After looking at potential sites around Europe, we look forward to building Calysta's first plant in Teesside.
“Teesside remains an important centre for the process industry,” he added. “We are keen to capitalise on the area’s commercial attractiveness, technical skills and research and development expertise.
"Our plant will not only provide a boost for the economy of North East England, but will also support the UK’s goal to become a world leader in the emerging industrial biotechnology sector by generating game changing technology in gas fermentation and synergistic applications.”
Our BQ Bulletin emails will land in your inbox at 7.30am, Monday to Friday, with a mix of the latest local business news, national news, and features to inspire you. Sign up here!
Click here to read our privacy statement